Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1Breast 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Lymphedema 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Docetaxel 6Radiotherapy 5Filgrastim 3Erlotinib Hydrochloride 3Cetuximab 3Capecitabine 3Bevacizumab 3entrectinib 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Fluorodeoxyglucose F18 2Cisplatin 2Chemotherapy, Adjuvant 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1tanespimycin 1spartalizumab 1sargramostim 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1cevimeline 1alectinib 1aldesleukin 1X-Ray Therapy 1Vorinostat 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Moxibustion × CNS × Clear all
NCT00828516 2013-01-17

AMWELL-SL

East and North Hertfordshire NHS Trust

Phase NA Completed
56 enrolled 6 charts
BreastCNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Head and Neck Neoplasms, Lymphedema, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡